HOME >> BIOLOGY >> NEWS
Scientist honored with second-most cited research paper of the decade

Wladek Minor's busy laboratory inside Jordan Hall at the University of Virginia Health System is famous for strong cappuccino and European chocolates. But now there's something a lot bigger to crow about- the esteem of his competitive scientific colleagues around the world.

A professor of molecular physiology and biological physics and a native of Poland, Minor is a pioneer in the growing field of protein crystallography. His lab's work is not going unnoticed. A 1997 paper, "Processing of X-ray Differentiation Data Collected in Oscillation Mode," published with Zbyszek Otwinowski, a colleague at the University of Texas, is now the second-most cited scientific paper in the world in the last ten years, according to The Scientist magazine. The title may glaze the eyes of a layman, but the discovery is a building block of science and may one day help doctors treat cancer patients or people with viruses. "We are trying to elucidate the 3-dimensional structure of protein molecules which will hopefully lead to new cures for a host of diseases," Minor said.

Inside the Minor lab, a joyful polyglot of languages- Polish, Chinese, English- fills the air, usually seven days a week, amid chemical bottles, beakers, machines and microscopes. Minor's scientists use personal digital assistants (PDA's) connected to a central server to track all their experiments.

Minor and his ambitious team are tearing apart tiny proteins, trying to figure out the relationship between their structure and function. Their goal is to solve one of the greatest mysteries in intelligent drug design- how specific, targeted drugs can kill viruses or cancer cells by finding their way around the human body's complex chemistry and innumerable defenses.

The 1997 paper describes a computer program used to process the data coming from X-ray experiments made on protein crystals. The program is now used in over 1,200 laboratories worldwide and has been improved over the years. Mino
'"/>

Contact: Bob Beard
bobbeard@virginia.edu
434-982-4490
University of Virginia Health System
17-Jan-2006


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientist honored with second most cited research paper the decade

(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/17/2015)... 2015 Emotient, the leader in facial ... general availability of Emotient Analytics , the ... of facial expressions. The system analyzes videos of ... and services. It delivers audience response metrics - ... as derived from facial evidence of emotional states. ...
(Date:3/12/2015)... BERLIN , March 12, 2015 ... IAM, a standardized identity and access management (IAM) ... reliable implementation schedule. With Beta System,s new IAM ... and best practices gleaned from multiple IAM implementations ... includes the software as well as any necessary ...
Breaking Biology News(10 mins):NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2
(Date:4/2/2015)... 02, 2015 InGaAs PIN photo diodes ... sensitivity and high-speed response. Marktech introduces the newest series ... can with active areas of 0.1mm, 0.3mm and 0.8mm. ... and high speed fiber modules. , Standard spectral range ... These parts offer considerable speed improvements over the current ...
(Date:4/1/2015)... , April 1, 2015  Adaptive Biotechnologies ... The Lancet Oncology showing that ... company,s next-generation sequencing-based minimal residual disease (MRD) detection ... MRD test) accurately identifies patients with diffuse large ... relapse after initial treatment, usually several months before ...
(Date:4/1/2015)... -- Emerson Ecologics is excited to announce its first ... . The conference will provide integrative healthcare practitioners with ... fulfilling practice. Scheduled for November 13-15, ... the conference will be a one-of-a-kind, "get it done" ... and leave with an action plan in hand. Highlights ...
(Date:4/1/2015)... , April 1, 2015  ValGenesis Inc., the market ... today that it has completed its Service Organization Controls ... Engagements (AICPA, Professional Standards) for the period of January ... 2014.  ... The SOC 2 examination ...
Breaking Biology Technology:Marktech Optoelectronics Announces High Speed InGaAs PIN Diode 1.7µm 2Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 2Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 3Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 4Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 5Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 2Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 3ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 2ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101 3
Cached News: